Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- GS +1.4%, MS +1.3%
Other news:
- HMST +13.3% (HomeStreet and FirstSun Capital Bancorp announce transformational strategic merger and $175 million equity raise; parties expect the closing of the merger to occur in the middle of 2024)
- TAST +12.7% (Carrols Restaurant Group and Restaurant Brands Int'l (QSR) reach agreement in which QSR will acquire all of Carrols issued and outstanding shares that are not already held by QSR or its affiliates for $9.55/shareshare)
- EFXT +4.8% (provides Full-Year 2023 update and preliminary outlook for 2024)
- ARQT +3.3% (ZORYVE (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids)
- TTI +2.7% (announces $190 million 6-year funded term loan to refinance maturing debt and a $75 million delayed draw term loan to provide capital for the planned bromine processing project)
- DCGO +2.5% (provides additional information to refute misleading short seller "report")
- UEC +1.8% (restarts 100% unhedged uranium production in Wyoming)
- BOWL +1% (promotes Lev Ekster to President)
Analyst comments:
- BROS +2.3% (upgraded to Buy from Hold at Stifel)
- CAMT +1.3% (upgraded to Overweight from Equal Weight at Barclays)
- COHR +1.3% (upgraded to Overweight from Equal Weight at Barclays)
- DOCU +0.9% (upgraded to Equal-Weight from Underweight at Morgan Stanley)